...
首页> 外文期刊>Journal of Medicinal Chemistry >Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin _1 and _3 receptors contributing to the insurmountable mode of antagonism by dual NK 1/NK 3 antagonists
【24h】

Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin _1 and _3 receptors contributing to the insurmountable mode of antagonism by dual NK 1/NK 3 antagonists

机译:鉴定人类速激肽神经激肽_1和_3受体螺旋位置6.51处的关键氨基酸,这是双重NK 1 / NK 3拮抗剂无法克服的拮抗方式

获取原文
获取原文并翻译 | 示例
           

摘要

The neurokinins are neuropeptides that elicit their effect through three GPCRs called NK _1, NK _2, and NK _3. Compounds 5 and 6 are dual hNK _1 (K _i of 0.7 and 0.3 nM) and hNK _3 (K _i of 2.9 and 1.7 nM) antagonists. Both compounds exhibit an insurmountable mode of antagonism at hNK 1, whereas at hNK 3, they differ in that 5 is an insurmountable but 6 a surmountable antagonist. Using homology modeling and site-directed mutagenesis, hNK 1-Phe264 and hNK 3-Tyr315 were found to be the molecular determinants of hNK _1 and hNK _3 antagonism by 5 and 6. In [3H]IP studies, the mutation hNK 1-F264Y converted the mode of action of 5 from insurmountable to partial insurmountable antagonism while it had no effect on that of 6. Conversely, the mutation hNK _3-Y315F enhanced the insurmountable behavior of 5 and converted 6's surmountable to an insurmountable antagonism. This finding was further confirmed by characterizing additional derivatives of 5 and 6, most notably with a hybrid structure.
机译:神经激肽是通过三个称为NK _1,NK _2和NK _3的GPCR发挥作用的神经肽。化合物5和6是双重hNK _1(K _i分别为0.7和0.3 nM)和hNK _3(K i分别为2.9和1.7 nM)拮抗剂。两种化合物在hNK 1上都显示出无法克服的拮抗作用,而在hNK 3上,它们的不同之处在于5是不可克服的拮抗作用,而6是可克服的拮抗作用。使用同源性建模和定点诱变,发现hNK 1-Phe264和hNK 3-Tyr315是5和6对hNK _1和hNK _3拮抗作用的分子决定因素。在[3H] IP研究中,hNK 1-F264Y突变。将5的作用方式从不可克服的拮抗作用转变为部分不可克服的拮抗作用,而对hNK _3-Y315F的突变则增强了5的不可克服的行为并将6的可克服的拮抗作用转化为不可克服的拮抗作用。通过表征5和6的其他衍生物,尤其是具有杂化结构,进一步证实了这一发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号